Excellent long-term outcome of renal transplantation in cystinosis patients
- PMID: 26208493
- PMCID: PMC4515017
- DOI: 10.1186/s13023-015-0307-9
Excellent long-term outcome of renal transplantation in cystinosis patients
Abstract
Background: Cystinosis is a rare lysosomal disorder leading to end stage renal disease in more than 90 % of patients before 20 years of age. Data about safety and efficiency of renal transplantation in patients with cystinosis is scarce. We evaluated long-term outcomes of renal transplantation in adult patients with cystinosis.
Methods: Data of renal transplantation (n = 31) in 30 adult patients with cystinosis in 5 French university transplant centers between 1980 and 2013 were retrospectively analyzed. A control cohort of 93 patients was matched for age, graft date, living/deceased donor status and transplant center.
Results: Median age at transplantation was 20.4 years (7-36.5). At transplantation, all patients with cystinosis had corneal cystine deposits, 3 had diabetes and 7 had hypothyroidism. Graft survival was better in patients with cystinosis than in control patients (p = 0.013). Multivariate analysis confirmed that cystinosis was an independent protective factor for graft survival (Hazard Ratio (HR) 0.11; CI95 [0.02-0.61]). Specific complications of cystinosis occurred during follow up: diabetes mellitus (n = 4), hypothyroidism (n = 1), liver involvement (n = 1), neurologic involvement (n = 2). Proportion of post-transplant diabetes mellitus (PTDM) was not statistically different in cystinosis group compared to control group: 4 (13.0 %) compared to 5 (5.0 %), respectively (p = 0.25), with no differences regarding calcineurin inhibitors and steroids treatments during follow-up.
Conclusions: Renal transplantation appears to be safe with excellent long-term outcomes in patients with cystinosis. These patients may receive standard immunosuppressive regimens with steroids and calcineurin inhibitors.
Figures


Similar articles
-
Follow-up and treatment of renal transplantation with nephropathic cystinosis in central Taiwan.Transplant Proc. 2012 Jan;44(1):80-2. doi: 10.1016/j.transproceed.2011.12.071. Transplant Proc. 2012. PMID: 22310585
-
Renal transplantation for infantile cystinosis: long-term follow-up.J Pediatr Surg. 1993 Feb;28(2):232-8. doi: 10.1016/s0022-3468(05)80282-9. J Pediatr Surg. 1993. PMID: 8437088 Review.
-
[Cystinosis in adults: A systemic disease].Nephrol Ther. 2015 Jun;11(3):152-9. doi: 10.1016/j.nephro.2014.12.001. Epub 2015 Mar 11. Nephrol Ther. 2015. PMID: 25769364 Review. French.
-
Course of nephropathic cystinosis after age 10 years.J Pediatr. 1986 Oct;109(4):605-8. doi: 10.1016/s0022-3476(86)80221-9. J Pediatr. 1986. PMID: 3531450
-
A single center experience of combined liver kidney transplantation.Clin Transplant. 2009 Dec;23 Suppl 21:102-14. doi: 10.1111/j.1399-0012.2009.01146.x. Clin Transplant. 2009. PMID: 19930323 Review.
Cited by
-
Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.Clin Ophthalmol. 2018 Jan 24;12:227-236. doi: 10.2147/OPTH.S133516. eCollection 2018. Clin Ophthalmol. 2018. PMID: 29416314 Free PMC article. Review.
-
Monogenic Kidney Diseases in Kidney Transplantation.Kidney Int Rep. 2023 Dec 13;9(3):549-568. doi: 10.1016/j.ekir.2023.12.003. eCollection 2024 Mar. Kidney Int Rep. 2023. PMID: 38481491 Free PMC article. Review.
-
Cystinosis: a review.Orphanet J Rare Dis. 2016 Apr 22;11:47. doi: 10.1186/s13023-016-0426-y. Orphanet J Rare Dis. 2016. PMID: 27102039 Free PMC article. Review.
-
Newborn Screening: Review of its Impact for Cystinosis.Cells. 2022 Mar 25;11(7):1109. doi: 10.3390/cells11071109. Cells. 2022. PMID: 35406673 Free PMC article. Review.
-
Adult complications of nephropathic cystinosis: a systematic review.Pediatr Nephrol. 2021 Feb;36(2):223-236. doi: 10.1007/s00467-020-04487-6. Epub 2020 Feb 3. Pediatr Nephrol. 2021. PMID: 32016627
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical